We're so glad you're here! This site is to help anyone diagnosed with Medullary Thyroid Cancer and their caregivers find valuable information and support. If you'd like to connect with others with MTC, please consider joining our very active Facebook Group. You don't have to go through this alone!
If you don't yet have a copy, please download the American Thyroid Association Guidelines for the Management of Medullary Thyroid Carcinoma, aka "The Guidelines." This is the MTC Bible. Read it and know it and it will help you and your doctor ensure you get the proper treatment.
Lastly, please consider looking into being seen by an MTC expert. We do our best to keep a running list of what we call "Centers of Excellence." These are doctors and facilities that are properly trained and experienced enough to treat MTC patients. It's one of the most important decisions you can make on your journey.
"LOXO-260, also known as LY3838915, is an oral smallmolecule drug designed to block tumors driven by changes in the RET gene. It targets patients ..."
"... thyroid gland pose significant diagnostic challenges due to their ability to mimic thyroid lesions. ... Medullary Thyroid Carcinoma Masquerading as ..."
"... thyroid cancer: papillary, follicular, medullary and anaplastic thyroid cancer. Other, less common types include Non-Invasive Follicular Thyroid ..."
"Who this is not for includes anyone who is pregnant or planning pregnancy, has a personal or family history of medullary thyroid cancer, or uses ..."
"People with a personal or family history of medullary thyroid carcinoma, multiple endocrine neoplasia syndrome type 2, or severe GI motility disorders ..."
This website is intended for educational purposes only. It is not intended, nor should it be interpreted, as medical advice or instructions of any kind. Readers are advised to consult their own medical doctor(s) for all matters involving their health and medical care.